Scinai Immunotherapeutics Ltd ADR (NQ: SCNI )
4.310
-0.080
(-1.82%)
Streaming Delayed Price
Updated: 11:58 AM EDT, Jul 22, 2024
Add to My Watchlist
All News about Scinai Immunotherapeutics Ltd ADR
Potential Complications of Untreated Psoriasis
November 02, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 01, 2024
Via Benzinga
Autoimmunity Patients Face Cost, Diagnosis, Care Challenges
November 28, 2023
New, Deadly Infectious Diseases Could Emerge as Climate Change Worsens
November 14, 2023
Topics
Climate Change
Exposures
Climate
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receive $900K IIA Grant for New CDMO Business Unit
November 07, 2023
Topics
Economy
Exposures
Economy
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance
November 03, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Study Identifies Immune Cells Responsible for Severe Asthma
October 30, 2023
![](https://ml.globenewswire.com/media/b6a75312-9fd6-45b6-8875-63e106163ea9/small/scinai-logo-whitespace-border-002-jpg.jpg)
Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023
October 30, 2023
Via GlobeNewswire
Five Ways to Treat Infectious Diseases While Keeping Antimicrobial Resistance in Check
October 23, 2023
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
October 12, 2023
Via Benzinga
Syndromic Testing Could Transform Infectious Disease Diagnosis
October 11, 2023
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.